WOLFGANG WINKELMAYER to Citalopram
This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Citalopram.
Connection Strength
0.252
-
Proton pump inhibitors may enhance the risk of citalopram- and escitalopram-associated sudden cardiac death among patients receiving hemodialysis. Pharmacoepidemiol Drug Saf. 2022 06; 31(6):670-679.
Score: 0.200
-
The modifying effect of the serum-to-dialysate potassium gradient on the cardiovascular safety of SSRIs in the hemodialysis population: a pharmacoepidemiologic study. Nephrol Dial Transplant. 2022 10 19; 37(11):2241-2252.
Score: 0.052